FRZB and hereditary leiomyomatosis and renal cell cancer: The HLRCC tumors showed methylation-associated downregulation of SFRP1, FRZB (previously known as SFRP3), and WNT3 mRNA expression, all components of the WNT pathway, but no downregulation of DKK1 (S3 Fig in S1 File).